blue cross blue shield fep glp 1 coverage of Mass. sees gains after years of GLP-1-related losses Why Blue Cross Blue Shield

A drugs half-life is a big clue for figuring out how long it remains in your body

In female users of GLP-1 drugs, those rates were 5.44% with tirzepatide versus 3.63% with semaglutide, the researchers said

Methods: The expression of senescent markers (p16 INK4a and p21 WAF1/Cip1 ), various SASPs such as CCL2 and interferon induced protein with tetratricopeptide repeats 3 (IFIT3), dysregulated autophagy marker p62 and PD-L1 were immunohistochemically examined in livers taken from the patients with PBC (n=87

doi:10.1016/j.gie.2020.08.023 39Bazerbachi F, Vargas EJ, Rizk M, et al

Your body is adjusting

Some GLP-1 injections come pre-filled as easy-to-use pens (like an EpiPen), while others come as vials and separate syringes that you must measure yourself